Clinical Trials: How to Find One and What Joining Involves

Maybe your oncologist mentioned a clinical trial. Or maybe you read about a new drug and wonder how people get it. Clinical trials can feel confusing, and some people fear being a "test subject". This guide explains what trials are, how to find one, and what happens if you join.

What a clinical trial is

A clinical trial is a research study in people. It tests whether a new treatment, test, or way of giving care is safe and works better than what we use now. [1] Every treatment your doctor uses today was tested in trials first.

Trials follow a written plan called a protocol. An ethics board must approve the plan before the trial starts. In the US this is an institutional review board, and in Canada it is a research ethics board. These boards protect the rights and safety of people who take part. [1]

The phases of a trial

New treatments move through phases. [1]

• Phase 1: tests safety and the best dose in a small group of people.
• Phase 2: tests whether the treatment works for a certain cancer, and checks safety in more people.
• Phase 3: compares the new treatment with the current standard treatment in a large group. These trials often decide whether a treatment becomes standard care.
• Phase 4: studies a treatment after approval, to learn about long-term effects.

Randomization and placebo

In many phase 3 trials, a computer assigns you by chance to one group. This is called randomization. It makes the groups fair so the results are trustworthy.

In cancer trials, a placebo (an inactive pill or shot) alone is rare when a good treatment exists. More often, everyone gets standard care, and the trial adds the new treatment or a placebo on top. [1]

What your doctor looks at

Each trial has rules about who can join. These are called eligibility criteria. Your team checks them carefully. Common criteria include: [1]

• Cancer type and stage.
• Results of biomarker or genetic tests on your tumor.
• Past treatments you have had.
• How well you can do daily activities, often called performance status.
• Kidney, liver, heart, and blood test results.
• Other health conditions and medications.

Why few people join

Fewer than 1 in 10 adults with cancer join a trial. A large review found that the biggest reason was simple: for more than half of patients, no fitting trial was open at their cancer center. Others did not meet the eligibility rules. [4] This is why it helps to ask early, and to ask whether a trial at another center might fit.

How to find a trial

• Ask your oncologist directly: "Is there a clinical trial for me?"
• Search ClinicalTrials.gov. It lists trials in the US, Canada, and many other countries. You can search by condition and location. [2]
• In the US, the National Cancer Institute has a search tool for trials it supports. [5]
• In Canada, provincial cancer agencies and large cancer centers list their open trials. Health Canada also keeps a public database of authorized clinical trials.
• Print the trial listing and bring it to your team. They can check whether you might qualify.

What joining involves

Informed consent

Before you join, a research team member goes over a consent form with you. It explains the purpose, the tests and visits, the possible risks and benefits, and the other options. You can take it home, ask questions, and talk with family. You sign only if you agree. [1]

You can leave a trial at any time. Leaving does not affect your right to standard care. [1]

Visits and tests

Trials often need more visits, blood tests, and scans than standard care. Ask how often you must come in and how far you will travel.

Costs

• In the US, the trial sponsor often pays for the study drug and research-only tests. Many health plans, including Medicare, must cover routine care costs in qualifying trials. Ask your insurer and the trial team. [3]
• In Canada, provincial health plans usually cover standard care. The sponsor usually provides the study drug. Ask about travel, parking, and time off work.

Possible benefits and risks

Every trial has trade-offs. The consent form lists them, but it helps to think them through.

Possible benefits:

• Access to a new treatment before it is widely available.
• Close follow-up from a research team.
• Helping future patients, even if the new treatment does not help you.

Possible risks:

• The new treatment may have side effects that are not yet known.
• The new treatment may not work better than standard care.
• You may not get the new treatment if you are assigned to the standard group.
• Extra visits and tests take time.

Questions to ask your clinician

• Is there a clinical trial that fits my cancer and stage?
• What phase is the trial, and what is it testing?
• What are the possible benefits and risks compared with standard treatment?
• Could I get a placebo, and would I still get standard care?
• How many extra visits, tests, or scans would I need?
• Who pays for the study drug, tests, and travel?
• What happens if I leave the trial, or when the trial ends?

Bottom line

Clinical trials are how cancer care gets better. They may give you access to new treatments, with close follow-up and strong safety rules. They also take time and may have unknown risks. Ask about trials early, search ClinicalTrials.gov, and review the consent form with your team before you decide.

Primary AI can show you the guideline and study sources behind this topic in plain language, so you can bring better questions to your appointment.